Actinium Pharmaceuticals, Inc.

ATNM

$1.01

Name : Actinium Pharmaceuticals, Inc.

Sector : Healthcare

Industry: Biotechnology

Mark. Cap: $31,688,744.00

EPSttm : -0.76

Actinium Pharmaceuticals, Inc.

$1.01

4.72%

$0.05

ATNM — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

3.44

Margin Of Safety %

Put/Call OI Ratio

0.05

EPS Next Q Diff

-0.05

EPS Last/This Y

0.25

EPS This/Next Y

0.36

Price

1.02

Target Price

5.75

Analyst Recom

Performance Q

-14.88

Upside

-1,046.6%

Beta

-0.01

Ticker: ATNM

20 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-05-11	ATNM	1.32	0.03	0.00	3337
2026-05-12	ATNM	1.29	0.03	0.00	3347
2026-05-13	ATNM	1.3	0.03	0.00	3350
2026-05-14	ATNM	1.28	0.03	0.00	3350
2026-05-15	ATNM	1.25	0.03	0.00	3410
2026-05-18	ATNM	1.16	0.07	0.00	919
2026-05-19	ATNM	1.18	0.07	0.00	930
2026-05-20	ATNM	1.17	0.07	0.00	1026
2026-05-21	ATNM	1.18	0.06	0.00	1106
2026-05-22	ATNM	1.17	0.06	0.00	1108
2026-05-26	ATNM	1.16	0.05	0.00	1113
2026-05-27	ATNM	1.17	0.04	999.99	1409
2026-05-28	ATNM	1.15	0.04	5.00	1410
2026-05-29	ATNM	1.255	0.05	0.00	1421
2026-06-02	ATNM	1.24	0.05	0.00	1463
2026-06-03	ATNM	1.16	0.05	0.42	1475
2026-06-04	ATNM	1.12	0.05	0.05	1489
2026-06-05	ATNM	1.075	0.05	0.00	1470
2026-06-08	ATNM	1.045	0.05	0.00	1470
2026-06-09	ATNM	1.03	0.05	0.13	1480
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

20 items 1 of 1

21 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-05-11	ATNM	1.32	56.9	-	-0.89
2026-05-12	ATNM	1.29	56.9	14.4	-0.89
2026-05-13	ATNM	1.29	56.9	91.0	-0.89
2026-05-14	ATNM	1.26	56.9	-	-0.89
2026-05-15	ATNM	1.26	56.9	-	-0.89
2026-05-18	ATNM	1.16	-9.1	-	-0.89
2026-05-19	ATNM	1.18	-9.1	-	-0.89
2026-05-20	ATNM	1.16	6.8	-	-0.84
2026-05-21	ATNM	1.18	6.8	-	-0.84
2026-05-22	ATNM	1.16	6.8	-	-0.84
2026-05-26	ATNM	1.15	6.8	-	-0.84
2026-05-27	ATNM	1.17	6.8	-	-0.84
2026-05-28	ATNM	1.15	6.8	-	-0.84
2026-05-29	ATNM	1.26	6.8	-	-0.84
2026-06-01	ATNM	1.21	6.8	-	-0.84
2026-06-02	ATNM	1.24	6.8	-	-0.84
2026-06-03	ATNM	1.15	6.8	-	-0.84
2026-06-04	ATNM	1.12	6.8	-	-0.84
2026-06-05	ATNM	1.06	6.8	-	-0.84
2026-06-08	ATNM	1.05	6.8	-	-0.84
2026-06-09	ATNM	1.02	6.8	-	-0.84
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

21 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-05-11	ATNM	0.00	0.71	3.60
2026-05-12	ATNM	0.00	0.71	3.49
2026-05-13	ATNM	0.00	0.71	3.49
2026-05-14	ATNM	0.00	0.71	3.49
2026-05-15	ATNM	0.00	0.71	3.49
2026-05-18	ATNM	0.00	0.30	3.49
2026-05-19	ATNM	0.00	0.30	3.49
2026-05-20	ATNM	0.00	0.30	3.49
2026-05-21	ATNM	0.00	0.30	3.49
2026-05-22	ATNM	0.00	0.30	3.49
2026-05-26	ATNM	0.00	-0.37	3.49
2026-05-27	ATNM	0.00	-0.37	3.49
2026-05-28	ATNM	0.00	-0.37	3.44
2026-05-29	ATNM	0.00	-0.37	3.44
2026-06-02	ATNM	0.00	-0.93	3.44
2026-06-03	ATNM	0.00	-0.93	3.44
2026-06-04	ATNM	0.00	-0.93	3.44
2026-06-05	ATNM	0.00	-0.93	3.44
2026-06-08	ATNM	0.00	-0.93	3.44
2026-06-09	ATNM	0.00	-0.93	3.44
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

Last Quarter Act. EPS

-0.18

Avg. EPS Est. Current Quarter

-0.2

Avg. EPS Est. Next Quarter

-0.23

Insider Transactions

Institutional Transactions

-0.93

Beta

-0.01

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

93.2

Max Drawdown 5-Year %

-93.2

Target Price

5.75

P/E

Forward P/E

PEG

P/S

359.1

P/B

14.03

P/Free Cash Flow

EPS

-0.75

Average EPS Est. Cur. Y

-0.84

EPS Next Y. (Est.)

-0.48

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-26078.89

Relative Volume

0.78

Return on Equity vs Sector %

-100

Return on Equity vs Industry %

-100

EPS 1 7Days Diff

EPS 1 30Days Diff

0.05

EBIT Estimation

◆ ATNM Healthcare

$1.03

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

20/20

Pullback

23/25

Volume

9/15

Valuation

12/20

TP/AR

2/10

Options

6/10

RSI

36.7

Range 1M

5.4%

Sup Dist

1.2%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

8/25

Growth

15/30

Estimates

0/20

Inst/Vol

0/15

Options

10/10

EPS Yr

24.1%

EPS NY

4.1%

52W%

7.9%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +458.3% upside

Quality

2/30

Valuation

16/30

Growth

12/25

Stability

5/10

LT Trend

4/5

Upside

+458.3%

Quality

Actinium Pharmaceuticals, Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 25

Actinium Pharmaceuticals, Inc. develops antibody radiation conjugates and other targeted radiotherapies intended to improve outcomes for people who have failed existing oncology therapies. The company offers Actimab-A, a CD33 targeting radiotherapeutic for patients with Relapsed/Refractory AML which is in to a Phase 2/3 Trial; and Iomab-ACT, to improve patient access to and outcomes with cellular therapies, such as CAR-T and gene therapies for non-malignant hematologic disorders such as sickle cell disease. It also develops ATNM-400, a antibody radioconjugate that deliver alpha-emitter Ac-225 to prostate cancer cells. In addition, the company's Iomab-B is an induction and conditioning agent prior to bone marrow transplant in patients with relapsed and refractory acute myeloid leukemia. Further, it engages with the National Cancer Institute under the cooperative research and development agreement for the development of Actimab-A in AML and other myeloid malignancies, and its research and development activities primarily focus on advancing various preclinical programs for solid tumor indications. The company is based in New York, New York.

ATNM

Latest News

—

Caricamento notizie per ATNM…

stock quote shares ATNM – Actinium Pharmaceuticals Inc Stock Price stock today

news today ATNM – Actinium Pharmaceuticals Inc stock forecast ,stock prediction 2023 2024 2025

marketwatch ATNM – Actinium Pharmaceuticals Inc yahoo finance google finance

stock history ATNM – Actinium Pharmaceuticals Inc invest stock market

stock prices ATNM premarket after hours

ticker ATNM fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: ATNM

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y